Bookbuilding IPO | ₹33 Cr | Listed at NSE SME | Wed, Mar 29, 2023 - Mon, Apr 3, 2023
Sotac Pharmaceuticals IPO is a book build issue of ₹33.30 crores. The issue is entirely a fresh issue of 0.30 crore shares of ₹33.30 crore.
Sotac Pharmaceuticals IPO bidding started from Mar 29, 2023 and ended on Apr 3, 2023. The allotment for Sotac Pharmaceuticals IPO was finalized on Apr 10, 2023. The shares got listed on NSE SME on Apr 13, 2023.
Sotac Pharmaceuticals IPO price band is set at ₹111 per share. The lot size for an application is 1,200. The minimum amount of investment required by an retail is ₹1,33,200 (1200 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (2,400 shares), amounting to ₹2,66,400.
Beeline Capital Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. The Market Maker of the company is Sunflower Broking Pvt.Ltd..
Refer to Sotac Pharmaceuticals IPO RHP for detailed Information.
IPO Open
Wed, Mar 29, 2023
IPO Close
Mon, Apr 3, 2023
Issue Price
₹111 per share
Market Cap (Pre-IPO)
₹122.66 Cr
| IPO Date | 29 Mar to 3 Apr, 2023 |
| Listed on | Thu, Apr 13, 2023 |
| Face Value | ₹10 per share |
| Price Band | ₹105 to ₹111 |
| Issue Price | ₹111 per share |
| Lot Size | 1,200 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 30,00,000 shares (agg. up to ₹33 Cr) |
| Reserved for Market Maker | 1,50,000 shares Sunflower Broking Pvt.Ltd. (agg. up to ₹2 Cr) |
| Fresh Issue (Ex Market Maker) | 28,50,000 shares (agg. up to ₹32 Cr) |
| Net Offered to Public | 28,50,000 shares (agg. up to ₹32 Cr) |
| Share Holding Pre Issue | 80,50,000 shares |
| Share Holding Post Issue | 1,10,50,000 shares |
| NSE Symbol | SOTAC |
| ISIN | INE0O2D01012 |
Sotac Pharmaceuticals IPO comprises a total issue size of 30,00,000 shares. The net offer to the public is 28,50,000 shares, after excluding 1,50,000 shares allotted on a firm basis. Of the Net offer 14,23,200 (49.94%) are allocated to QIB, 4,28,400 (15.03%) allocated to NII 9,98,400 (35.03%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| QIB Shares Offered | 14,23,200 | 49.94% | 47.44% |
| − Anchor Investor Shares Offered | 8,53,200 | 28.44% | |
| − QIB (Ex. Anchor) Shares Offered | 5,70,000 | 19.00% | |
| NII (HNI) Shares Offered | 4,28,400 | 15.03% | 14.28% |
| Retail Shares Offered | 9,98,400 | 35.03% | 33.28% |
| Firm Reservations | |||
| Market Maker Shares Offered | 1,50,000 | 5.00% | |
| Total Shares Offered | 30,00,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 1,200 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,33,200 |
| Retail (Max) | 1 | 1,200 | ₹1,33,200 |
| HNI (Min) | 2 | 2,400 | ₹2,66,400 |
Sotac Pharmaceuticals IPO raises ₹9.47 crore from anchor investors. Sotac Pharmaceuticals IPO Anchor bid date is March 28, 2023.
📝 Anchor Investors Letter (PDF)
| Bid Date | Tue, Mar 28, 2023 |
| Shares Offered | 8,53,200 |
| Anchor Portion (₹ Cr.) | 9.47 |
| Anchor lock-in period end date for 50% shares (30 Days) | Wed, May 10, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | Sun, Jul 9, 2023 |
Incorporated in 2015, Sotac Pharmaceuticals Limited is a part of the SOTAC group, based in Gujarat. The company is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. The company's business is majorly on principle to principle basis with different marketers.
SOTAC is serving over 162 corporate clients on a loan license and/or contract manufacturing basis. With their vast experience in the pharmaceutical segment, the company is growing and enlarging its scale of operations every year.
Sotac Pharmaceuticals established its manufacturing facility in the year 2017. In the year, the company's manufacturing facility was installed with the capacity to manufacture 90 Crore tables/year, and 14 Crore Capsules/year.
With a combined experience of over 59 years in the pharmaceutical manufacturing Industry of the Promoters, the company is blooming and expanding in various horizons.
| Period Ended | 30 Sep 2022 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|
| Assets | 64.62 | 35.25 | 34.70 | 30.38 |
| Total Income | 39.95 | 73.37 | 48.95 | 28.83 |
| Profit After Tax | 0.47 | 2.88 | -2.37 | 0.09 |
| NET Worth | 7.97 | 6.62 | 2.49 | 3.06 |
| Reserves and Surplus | 5.67 | 4.32 | 0.19 | 0.76 |
| Total Borrowing | 21.86 | 11.35 | 10.36 | 0.15 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Working Capital Requirements | 10.80 |
| 2 | Investment in Subsidiary | 7.00 |
| 3 | Upgradation / Construction of Existing /New Building in the Existing Premises | 5.90 |
| 4 | General Corporate Purpose | 7.40 |
| KPI | |
|---|---|
| ROE | 53.1 |
| ROCE | 68.34 |
| Debt/Equity | 1.12 |
| RoNW | 43.47 |
| PAT Margin | 3.94% |
| EBITDA Margin | 8.39% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 3.58 | |
| P/E (x) | 132.14 | |
| Promoter Holding | 84.63% | |
| Market Cap | ₹122.66 Cr. |
The Sotac Pharmaceuticals IPO is subscribed 1.60 times on April 3, 2023 7:30:00 PM (Day 3). The public issue subscribed 0.91 times in the retail category, 1.00 times in the QIB category, and 4.04 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (x) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB (Ex Anchor) | 1.00 | 5,71,800 | 5,70,000 |
| NII* | 4.04 | 4,28,400 | 17,29,200 |
| Retail | 0.91 | 9,98,400 | 9,06,000 |
| Total | 1.60 | 19,98,600 | 32,05,200 |
Total Applications: 755
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manger Fees including Underwriting Commission | 1.92 |
| 2 | Fees Payable to Registrar to the Issue | 0.01 |
| 3 | Fees Payable Advertising, Marketing Expenses and Printing Expenses | 0.15 |
| 4 | Fees Payable to Regulators including Stock Exchanges and other Intermediaries | 0.05 |
| 5 | Fees payable to Peer Review Auditor | 0.01 |
| 6 | Fees Payable to Market Maker (for Two Years) | 0.06 |
| 7 | Escrow Bank Fees | 0.01 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹111.00 |
| Open | ₹115.00 |
| Low | ₹115.00 |
| High | ₹120.75 |
| Last Trade | ₹120.75 |
Lead Manager Reports
Sotac Pharmaceuticals IPO is a SME IPO of 30,00,000 equity shares of the face value of ₹10 aggregating up to ₹33 Crores. The issue is priced at ₹111 per share. The minimum order quantity is 1200.
The IPO opens on Wed, Mar 29, 2023, and closes on Mon, Apr 3, 2023.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Sotac Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Sotac Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Sotac Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Sotac Pharmaceuticals IPO opens on Wed, Mar 29, 2023 and closes on Mon, Apr 3, 2023.
Sotac Pharmaceuticals IPO lot size is 1200, and the minimum amount required for application is ₹1,33,200.
You can apply in Sotac Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Sotac Pharmaceuticals IPO will be done on Monday, April 10, 2023, and the allotted shares will be credited to your demat account by Wed, Apr 12, 2023. Check the Sotac Pharmaceuticals IPO allotment status.
The Sotac Pharmaceuticals IPO listing date is on Thu, Apr 13, 2023.
